Clinwave Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.21 M
as on 16-11-2024
- Revenue 19.12%
(FY 2023)
- Profit 19.99%
(FY 2023)
- Ebitda 14.12%
(FY 2023)
- Net Worth 45.36%
(FY 2023)
- Total Assets 52.56%
(FY 2023)
About Clinwave Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.21 M.
Sowjanya Tamma and Rajasekhara Tamma serve as directors at the Company.
- CIN/LLPIN
U73200TG2018PTC122734
- Company No.
122734
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Clinwave Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajasekhara Tamma  | Managing Director | 07-Mar-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sowjanya Tamma | Director | 07-Mar-2018 | Current |
Financial Performance of Clinwave Research.
Clinwave Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.12% increase. The company also saw a substantial improvement in profitability, with a 19.99% increase in profit. The company's net worth Soared by an impressive increase of 45.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinwave Research?
In 2023, Clinwave Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Blue Bricks Ventures Private LimitedActive 4 months 9 daysSowjanya Tamma and Rajasekhara Tamma are mutual person
- Wockridge Pharma Private LimitedActive 6 years 9 months
Sowjanya Tamma and Rajasekhara Tamma are mutual person
- Wockridge Global Healthcare Private LimitedActive 5 years 1 month
Sowjanya Tamma and Rajasekhara Tamma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Dec 2021 | ₹1.21 M | Open |
How Many Employees Work at Clinwave Research?
Unlock and access historical data on people associated with Clinwave Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinwave Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinwave Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
